Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Augusta
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Augusta, GA

Studies commonly pay $75 to $4,500 per completed study

184 clinical trials are currently recruiting participants within 30 miles of Augusta. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

184studies recruiting
5+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Augusta right now

Top 25 of 184 recruiting studies, sorted by proximity — each links to its official registry page

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Southeast Retina Center — Augusta, Georgia (9.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Southeast Retina Center, P.C. — Augusta, Georgia (9.2 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Ependymoma, Medulloblastoma Phase 1 Interventional 37 participants sought
Augusta University, Georgia Cancer Center — Augusta, Georgia (9.2 mi) · Sponsor: Theodore S. Johnson
See eligibility & contact on ClinicalTrials.gov (NCT05106296)

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

Intracerebral Hemorrhage, Stroke N/A Observational 1,018 participants sought
Augusta University-Neuroscience Center — Augusta, Georgia (9.2 mi) · Sponsor: Zeenat Qureshi Stroke Institute
See eligibility & contact on ClinicalTrials.gov (NCT06402968)

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm N/A Interventional 600 participants sought
Augusta Oncology Associates PC-D'Antignac — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06279013)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Breast Cancer, Breast Cancer Metastatic Phase 1, Phase 2 Interventional 150 participants sought
Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Incyclix Bio
See eligibility & contact on ClinicalTrials.gov (NCT05735080)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Phase 1 Interventional 65 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05950464)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 182 — Augusta, Georgia (9.2 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07482176)

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases Phase 3 Interventional 400 participants sought
Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT06806592)

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

CKD, Metabolic Acidosis Phase 3 Interventional 150 participants sought
Southeastern Clinical Research Institute — Augusta, Georgia (9.2 mi) · Sponsor: Renibus Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07355062)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Schizophrenia, Schizoaffective Disorder Phase 4 Interventional 50 participants sought
Neurocrine Clinical Site — Augusta, Georgia (9.2 mi) · Sponsor: Neurocrine Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07105111)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Sickle Cell Disease Phase 3 Interventional 315 participants sought
Augusta University Georgia — Augusta, Georgia (9.2 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06439082)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT04322318)

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Phase 3 Interventional 350 participants sought
Ascentage Investigative Site #1045 — Augusta, Georgia (9.2 mi) · Sponsor: Ascentage Pharma Group Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06051409)
Google-rated

Top-rated research centers in Augusta

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Southeastern Clinical Research Institute

1521 Anthony Rd, Augusta, GA 30904
(706) 922-3005

Masters of Clinical Research

1232 Augusta W Pkwy, Augusta, GA 30909
(706) 210-8890

Telemedicine & Advanced Technology Research Center (TATRC) Digital Health Innovation Center (DHIC)

300 E Hospital Rd, Fort Gordon, GA 30905
(301) 619-7927

Georgia Prevention Institute

★ 4.8
1499 Walton Wy, Augusta, GA 30912
(706) 721-4534
"A place for and of exercise and health that lives up to the standard of pushing yourself. I am still sore."
— Richard Drake, 4★

Georgia Cancer Center - M. Bert Storey Research Building

★ 5.0
1410 Laney Walker Blvd, Augusta, GA 30912
(706) 721-0570
"Such professional caring care throughout all stages of care - from physicians to auxiliary medical care to clinic and infusion nurses to medical assi…"
— Genie Fulcher, 5★

Clinical trials in Augusta: what's recruiting

The Augusta area currently has 184 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Augusta, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism2 studies
  • Immune & Skin1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Augusta, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Augusta

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Augusta participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How do I join a study in Augusta, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Augusta?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Augusta?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Augusta.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Augusta typically complete one or two studies per year.

Paid clinical trials near Augusta

Other metros within reach

Columbia, SC201 Athens, GA69 Mauldin, SC382 Greenville, SC382 Spartanburg, SC367 Savannah, GA176 Macon, GA74 Warner Robins, GA74

More of GA

Atlanta1,673 Savannah176 Gainesville149 Macon74 Warner Robins74 Athens69 Columbus67

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts